Abstract: The method includes a first step of providing a housing with a hollow protrusion. A second step provides an auxiliary element in the hollow protrusion. A third step provides a connector receptacle in connection with the auxiliary element. A fourth step inserts a matching connector in the connector receptacle in a detachable way, the matching connector further including guiding means. A fifth step places a luminous module including a module connector, the module connector being helped by the guiding means to be connected to the matching connector, to achieve an electric connection between the module connector and the matching connector. A final step moves the connector receptacle so that the matching connector exits from the connector receptacle.

Abstract: The invention relates to the use of one or more cannabinoids, particularly THC and/or CBD in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM). The non-cannabinoid chemotherapeutic agent may be a selective estrogen receptor modulator or an alkylating agent.

Abstract: An electronic connection assembly comprises a base, a first connector assembly and a module connector. The base comprises a first opening and a second opening, the second opening comprising a slotted edge with a passage which connects the first opening and the second opening. The first connector assembly comprises a wire harness, a rim and a receiving connector which protrudes a connector height from the rim, the rim being adapted to be introduced into the slotted edge. The module connector is adapted to match with the receiving connector. Either the first connector assembly or the module connector comprises a funnelled guide.

Abstract: A tablet device holder assembly may include a housing defining a housing opening and including a housing lip arranged on a first side of the housing above the housing opening, and a removable bezel having a projection configured to extend through the housing opening and defining a projection opening that when the bezel is rotated to an installed state, the lip is received within the projection opening to maintain the bezel on the housing.

Abstract: The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multifonne (GBM).

Abstract: A method for manufacturing an automotive luminous device. This method comprises some steps. A first step comprises providing a housing with a hollow protrusion. A second step comprises providing an auxiliary element in the hollow protrusion. A third step comprises providing a connector receptacle in connection with the auxiliary element. A fourth step comprises inserting a matching connector in the connector receptacle in a detachable way, the matching connector further comprising guiding means. A fifth step comprises placing a luminous module comprising a module connector, the module connector being helped by the guiding means to be connected to the matching connector, thus achieving an electric connection between the module connector and the matching connector. A final step comprises moving the connector receptacle so that the matching connector exits from the connector receptacle.

Abstract: An electronic connection assembly comprises a base, a first connector assembly and a module connector. The base comprises a first opening and a second opening, the second opening comprising a slotted edge with a passage which connects the first opening and the second opening. The first connector assembly comprises a wire harness, a rim and a receiving connector which protrudes a connector height from the rim, the rim being adapted to be introduced into the slotted edge. The module connector is adapted to match with the receiving connector. Either the first connector assembly or the module connector comprises a funnelled guide.

Abstract: An automotive part for manufacturing an automotive lighting device housing, the automotive part including a first wall and a second wall. The first height of the first wall is greater than the wall distance, the first wall being suitable for being bent over the second wall thus creating a wire retainer.

Abstract: An attachment feature is provided for securing two workpieces together. That attachment feature includes a first wall, a second wall, and a cantilever snap extending between the two walls. Further, the attachment feature includes a first lateral rib projecting from the first wall and a second lateral rib projecting from the second wall. A workpiece assembly is also provided.

Abstract: The invention relates to the use of one or more cannabinoids, particularly THC and/or CBD in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM). The non-cannabinoid chemotherapeutic agent may be a selective estrogen receptor modulator or an alkylating agent.

Abstract: A tablet device holder assembly may include a housing defining an housing opening and including a housing lip arranged on a first side of the housing above the housing opening, and a removable bezel having a projection configured to extend through the housing opening and defining a projection opening that when the bezel is rotated to an installed state, the lip is received within the projection opening to maintain the bezel on the housing.

Abstract: A tablet device holder assembly may include a housing defining a housing opening and including a housing lip arranged on a first side of the housing above the housing opening, and a removable bezel having a projection configured to extend through the housing opening and defining a projection opening that when the bezel is rotated to an installed state, the lip is received within the projection opening to maintain the bezel on the housing.

Abstract: An applicator assembly includes a head portion having a proximal, a distal end, and an interior portion defining a fluid chamber, a container slidably coupled to the body, a sealing member sealing an end of the container, and a lifting member, wherein the lifting member is mounted in the interior portion of the head portion and an interior of the container is placed in fluid communication with the application member by way of a fluid conduit that is formed around the sealing member from the container to the fluid chamber when the container is axially translated toward the head portion and the lifting member lifts the sealing member.

Abstract: This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.

Abstract: A tablet device holder assembly may include a housing defining an housing opening and including a housing lip arranged on a first side of the housing above the housing opening, and a removable bezel having a projection configured to extend through the housing opening and defining a projection opening that when the bezel is rotated to an installed state, the lip is received within the projection opening to maintain the bezel on the housing.

Abstract: An applicator assembly includes a head portion having a proximal end, a distal end, and an interior portion defining a fluid chamber, a container slidably coupled to the head portion, a plug sealing an end of the container, an application member attached to the distal end, and one or more orifices formed through a surface of the plug, wherein the plug is mounted in the interior portion of the head portion and an interior of the container is placed in fluid communication with the application member by way of a fluid conduit that is formed through the plug from the container to the fluid chamber when the container is axially translated toward the head portion to bring the one or more orifices into fluid communication with the container.

Abstract: This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.

Abstract: An attachment feature is provided for securing two workpieces together. That attachment feature includes a first wall, a second wall, and a cantilever snap extending between the two walls. Further, the attachment feature includes a first lateral rib projecting from the first wall and a second lateral rib projecting from the second wall. A workpiece assembly is also provided.

Abstract: An applicator assembly includes a body having a proximal and a distal end, a container slidably coupled to the body, a valve cap coupled to the container, and an application member attached to the distal end, wherein an interior of the container is placed in fluid communication with the application member by way of a fluid conduit that is only accessible when one of the body and the container are axially translated in an opposite direction away from each other.

Abstract: An applicator assembly includes a container having a proximal end, a distal end, and an interior portion defining a chamber, an application member attached to the distal end of the container, and a tearable solution reservoir disposed within the chamber, the tearable solution reservoir comprising a tearing member, wherein actuating the tearing member to tear the tearable solution reservoir brings the container, the tearable solution reservoir, and the application member into fluid communication with each other.